<DOC>
	<DOCNO>NCT01661413</DOCNO>
	<brief_summary>Chemotherapy induce nausea common side effect child undergo chemotherapy . Furthermore , chemotherapy-induced vomit major factor limit quality life treatment report paediatric cancer survivor . Complete prevention nausea vomit goal anti-vomiting nausea medication . It important understand whether certain chemotherapeutic treatment less likely cause symptom . Acute leukemia common cancer diagnose child . Intrathecal methotrexate important part chemotherapy prevention treatment central nervous system leukemia 2.5 3.5 year treatment program leukemia . The likelihood intrathecal methotrexate administer monotherapy cause nausea vomit yet describe child . Knowledge likelihood intrathecal methotrexate cause nausea vomit therefore important optimize treatment side-effects chemotherapy . The primary aim prospective study evaluate potential intrathecal methotrexate cause nausea vomit paediatric cancer patient .</brief_summary>
	<brief_title>Nausea Vomiting Children Receiving Chemotherapeautic Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>4 year old 18 year age ( age range PeNAT validate ) [ 18 ] English speaking ( PeNAT validate English ) Cognitive ability child believe least 4 year old level accord parent health care professional Patients past first cycle maintenance therapy avoid interaction intensive chemotherapy phase . Receiving chemotherapy dictate protocol maintenance therapy within 24 hour prior 24 hour follow receipt intrathecal methotrexate</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Acute Leukemia</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Intrathecal methotrexate</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
</DOC>